In the US, Kengreal (cangrelor systemic) is a member of the drug class platelet aggregation inhibitors and is used to treat Percutaneous Coronary Intervention.
Ingredient matches for Kengreal
Cangrelor is reported as an ingredient of Kengreal in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.